跳至主要内容
临床试验/NCT02672462
NCT02672462Unknown不适用

The Safety and Efficacy of a Renal Denervation System in Treating Patients With Hypertension: A Pilot Study

Shanghai Golden Leaf MedTec Co. Ltd1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2015年12月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
20
试验地点
1
主要终点
blood pressure

研究概览

简要总结

A single center, self-controlled pilot study on safety and efficacy of renal denervation in treatment of hypertension.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Ages of 18 to 75, male or female;
  • Main renal artery, with or without accessary renal arteries, with length
  • Patients who have not taken any anti-hypertensive drugs or have been off drugs for at least 2 weeks, with mean SBP ≥150mmHg and
  • 180mmHg based on at least 3 office blood pressure measurements, or ASBP≥135mmHg and ≤170mmHg based on 24 hr blood pressure monitoring;
  • Agrees to take part in the trial and signs the written, informed consent.

排除标准

  • Renal artery abnormalities that are inappropriate for the procedure;
  • Pregnant or plan to become pregnant;
  • History of orthostatic hypotension;
  • Type I diabetes;
  • Estimated GFR<40mL/min/1.73m2;
  • Only one kidney or prior kidney transplantation;
  • Bleeding tendency or other coagulation related diseases;
  • Acute or severe systemic infection;
  • Prior renal artery interventional procedures or prior RDN treatment;
  • History of stroke or TIA;
  • Malignant tumor or end-stage illnesses;
  • Secondary hypertension;
  • Acute coronary events within 2 weeks;
  • Other conditions that deem unsuitable for the procedure, in the opinions of investigators.

结局指标

主要结局

blood pressure

时间窗: 6 months

次要结局

未报告次要终点

研究者

发起方
Shanghai Golden Leaf MedTec Co. Ltd
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验